Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-01-16 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages, total voting rights, and details of instruments held by a specific entity (DWS Investment GmbH) in MorphoSys AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. Although the header mentions 'Voting Rights Announcements', the content structure aligns perfectly with the 'Notification of Major Holdings' required under securities regulations, which is classified as MRQ in the provided schema.
2024-01-16 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'MorphoSys AG: Release according to Article 40, Section 1 of the WpHG' and explicitly contains a section titled 'Notification of Major Holdings'. It details changes in voting rights percentages held by BlackRock, Inc., crossing specific thresholds (3.14% shares, 0.20% instruments). This content directly corresponds to regulatory filings concerning significant changes in share ownership. Among the provided definitions, 'Major Shareholding Notification' (Code: MRQ) is the most appropriate fit for reporting changes in significant share ownership levels crossing thresholds, as indicated by the document's structure and content (WpHG notification regarding voting rights changes). Although it is a regulatory announcement, MRQ is more specific than the general RNS fallback.
2024-01-15 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and the breakdown of instruments (like options and swaps) held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The German regulatory context (WpHG) confirms this is a formal disclosure related to shareholdings. Therefore, the appropriate code is MRQ.
2024-01-09 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' as per German Securities Trading Act (WpHG) requirements. It details the acquisition/disposal of shares and instruments, crossing specific voting rights thresholds (Section 6 and 7). This type of mandatory disclosure regarding changes in significant share ownership directly maps to the definition of Major Shareholding Notification.
2024-01-09 English
MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Report Publication Announcement Classification · 1% confidence The document is a short news release dated January 8, 2024, announcing that MorphoSys AG's CEO will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024. This is an announcement about participation in an external industry conference, not a formal regulatory filing like a 10-K, an earnings release (ER), or a proxy statement. Since it is an announcement regarding an upcoming presentation at a major industry event, it most closely aligns with general investor relations communication. Given the options, it is not a specific report type (like 10-K, AR, IR) nor a specific corporate action (like DIV, CAP, DIRS). It is a general communication to investors about an event. While it could potentially be classified as a Regulatory Filing (RNS) as a catch-all, the content is specifically about a presentation at a major healthcare conference, which is a common type of investor event announcement. However, none of the codes explicitly cover 'Conference Presentation Announcement'. Given the options, and recognizing this is a standard corporate news release about an investor event, it fits best under the general 'Regulatory Filings' (RNS) category if it doesn't fit elsewhere, or potentially as a type of Investor Presentation (IP) if the announcement itself is considered the primary communication vehicle, but IP is usually the presentation material itself. Since this is just the *announcement* of the presentation, and it's not a formal regulatory filing like a 10-K or a specific report, RNS (Regulatory Filings / General Announcement) is the most appropriate fallback for this type of corporate news release that doesn't fit the other specific categories.
2024-01-08 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and instruments held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, referencing German Securities Trading Act (WpHG) articles. This structure perfectly matches the definition of a Major Shareholding Notification, which tracks changes in significant ownership thresholds. The code for this is MRQ.
2024-01-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.